Sarcopenia – Definition, Radiological Diagnosis, Clinical Significance

Abstract

Background Sarcopenia is an age-related syndrome characterized by a loss of muscle mass and strength. As a result, the independence of the elderly is reduced and the hospitalization rate and mortality increase. The onset of sarcopenia often begins in middle age due to an unbalanced diet or malnutrition in association with a lack of physical activity. This effect is intensified by concomitant diseases such as obesity or metabolic diseases including diabetes mellitus. Method With effective preventative diagnostic procedures and specific therapeutic treatment of sarcopenia, the negative effects on the individual can be reduced and the negative impact on health as well as socioeconomic effects can be prevented. Various diagnostic options are available for this purpose. In addition to basic clinical methods such as measuring muscle strength, sarcopenia can also be detected using imaging techniques like dual X-ray absorptiometry (DXA), computed tomography (CT), magnetic resonance imaging (MRI), and sonography. DXA, as a simple and cost-effective method, offers a low-dose option for assessing body composition. With cross-sectional imaging techniques such as CT and MRI, further diagnostic possibilities are available, including MR spectroscopy (MRS) for noninvasive molecular analysis of muscle tissue. CT can also be used in the context of examinations performed for other indications to acquire additional parameters of the skeletal muscles (opportunistic secondary use of CT data), such as abdominal muscle mass (total abdominal muscle area – TAMA) or the psoas as well as the pectoralis muscle index. The importance of sarcopenia is already well studied for patients with various tumor entities and also infections such as SARS-COV2. Results and Conclusion Sarcopenia will become increasingly important, not least due to demographic changes in the population. In this review, the possibilities for the diagnosis of sarcopenia, the clinical significance, and therapeutic options are described. In particular, CT examinations, which are repeatedly performed on tumor patients, can be used for diagnostics. This opportunistic use can be supported by the use of artificial intelligence. Key Points: Citation Format

CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis

“…One approach involves improving the accuracy of CT-based biomarkers. For instance, this could be achieved through the quantification of sarcopenia, which may be an important attribute in capturing fracture risk in older individuals [ 95 , 96 ]. In the context of cancer patients, a study revealed that muscle attenuation was not significantly different between patients with and without fractures [ 74 ].…”

Body composition analysis by radiological imaging – methods, applications, and prospects

“…Bei Patienten mit onkologischen Erkrankungen wird die körperliche Leistungsfähigkeit erfasst, um die Risiken von Morbidität und Mortalität abzuschätzen. Die krankheitsassoziierte und oft unbewusste Reduktion des Körpergewichts bei der Kachexie [38] kann nicht immer von der im Alter scheinbar physiologischen Abnahme der Muskelmasse im Rahmen der Sarkopenie unterschieden werden [39][40][41][42].…”

“…The physical fitness is often assessed in patients with oncological diseases to evaluate the risks of morbidity and mortality. The disease-related and often unknowing weight loss in cachexia [38] cannot always be differentiated from the age-related physiological loss of muscle mass in sarcopenia [39][40][41][42].…”

Examining the presence of sarcopenia in women with rheumatoid arthritis: Case-control study

“…Sarcopenia is a progressive skeletal muscle disorder that causes adverse conditions such as functional loss, mortality and morbidity as a result of the decrease in skeletal muscle mass and strength [6]. Sarcopenia is considered a specific disease [7].…”